Colinz Laboratories is in the business of manufacturing and trading in pharmaceutical formulationsBusiness Overview: http://www.colinz.com/about.html CLL is a manufacturer and exporter of pharmaceutical formulations for allopathic, ayurvedic, nutraceticals in dosage forms of tablets, capsules, ointments, creams, granules, liquid, orals, injectables, syrups, suppsitories, etc. It also has certain specialized products…
Colinz Laboratories Limited has announced its 40th Annual General Meeting (AGM) will be held via Video Conferencing on September 22. Shareholders will transact business as per the AGM notice, which was sent electronically. The company provides an e-voting facility, with the cut-off date for determining eligible voters being September 15....
Dear Sir,
Pursuant to Regulation 34(1) and Regulation 30 of SEBI(LODR),Regulations ,2015. Please find the attached our 40th Annual Report for the FY 2025-26. Kindly take the same on ....
Colinz has announced its 40th Annual General Meeting, to be held virtually. Shareholders can participate and cast their votes through remote e-voting. The company specified a cut-off date for determining eligible shareholders for voting, and the e-voting window will open and close a few days before the meeting. Additionally, a...
As required under SEBI (LODR)Regulaions, 2015 and Section 108 Companies Act 2013 Reas with Rule 20 and other Applicable Rules thereunder, we are submitting herewith 40th AGM Notice of our ....
Colinz Laboratories has announced a board meeting held on 30th July, 2026, where the audited financial results for the quarter ended 30th June, 2026, and the year ended 31st March, 2026, were approved. For the quarter, revenue from operations was 1.36 Cr, with a net profit of 2.40 Cr and...
